Literature DB >> 10205192

Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity.

D Nehra1, P Howell, C P Williams, J K Pye, J Beynon.   

Abstract

BACKGROUND: Bile acid toxicity has been shown in the gastric, colonic, and hepatic tissues; the effect on oesophageal mucosa is less well known. AIMS: To determine the spectrum of bile acids refluxing in patients with gastro-oesophageal reflux disease and its relation to oesophageal pH using a new technique of combined oesophageal aspiration and pH monitoring.
METHODS: Ten asymptomatic subjects and 30 patients with symptoms of gastro-oesophageal reflux disease (minimal mucosal injury, erosive oesophagitis (grade 2 or 3 Savary-Miller), Barrett's oesophagus/stricture; n=10 in each group) underwent 15 hour continuous oesophageal aspiration with simultaneous pH monitoring. Bile acid assay of the oesophageal samples was performed using modified high performance liquid chromatography.
RESULTS: The peak bile acid concentration and DeMeester acid scores were significantly higher in the patients with oesophagitis (median bile acid concentration 124 micromol/l; acid score 20.2) and Barrett's oesophagus/stricture (181 micromol/l; 43. 3) than patients with minimal injury (14 micromol/l; 12.5) or controls (0 micromol/l; 11.1). The predominant bile acids detected were cholic, taurocholic, and glycocholic acids but there was a significantly greater proportion of secondary bile acids, deoxycholic and taurodeoxycholic acids, in patients with erosive oesophagitis and Barrett's oesophagus/stricture. Although bile acid reflux episodes occurred at variable pH, a temporal relation existed between reflux of taurine conjugates and oesophageal acid exposure (r=0.58, p=0.009).
CONCLUSION: Toxic secondary bile acid fractions have been detected in patients with extensive mucosal damage. Mixed reflux is more harmful than acid reflux alone with possible toxic synergism existing between the taurine conjugates and acid.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10205192      PMCID: PMC1727508          DOI: 10.1136/gut.44.5.598

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  32 in total

1.  Assessment of combined bile acid and pH profiles using an automated sampling device in gastro-oesophageal reflux disease.

Authors:  D Nehra; P Howell; J K Pye; J Beynon
Journal:  Br J Surg       Date:  1998-01       Impact factor: 6.939

2.  Effect of pepsin on ionic permeability of canine esophageal mucosa.

Authors:  S Safaie-Shirazi
Journal:  J Surg Res       Date:  1977-01       Impact factor: 2.192

3.  Bile damage to the gastric mucosal barrier: the influence of pH and bile acid concentration.

Authors:  R B Black; D Hole; J Rhodes
Journal:  Gastroenterology       Date:  1971-08       Impact factor: 22.682

4.  Effect of bile salts and related compounds on isolated esophageal mucosa.

Authors:  E Kivilaakso; D Fromm; W Silen
Journal:  Surgery       Date:  1980-03       Impact factor: 3.982

5.  Effects of bile acids and hydrogen ion on the fine structure of oesophageal epithelium.

Authors:  D Hopwood; M C Bateson; G Milne; I A Bouchier
Journal:  Gut       Date:  1981-04       Impact factor: 23.059

6.  Competitive inhibition of intestinal bile salt absorption in the rat.

Authors:  P R Holt
Journal:  Am J Physiol       Date:  1966-03

7.  Bile acid composition in patients with and without symptoms of postoperative refulx gastritis.

Authors:  T R Gadacz; G D Zuidema
Journal:  Am J Surg       Date:  1978-01       Impact factor: 2.565

8.  Microflora and deconjugation of bile acids in alkaline reflux after partial gastrectomy.

Authors:  L Domellöf; B S Reddy; J H Weisburger
Journal:  Am J Surg       Date:  1980-08       Impact factor: 2.565

9.  Bile salt regulation of fatty acid absorption and esterification in rat everted jejunal sacs in vitro and into thoracic duct lymph in vivo.

Authors:  M L Clark; H C Lanz; J R Senior
Journal:  J Clin Invest       Date:  1969-09       Impact factor: 14.808

10.  Nature of tissue-bound lithocholic acid and its implications in the role of bile acids in carcinogenesis.

Authors:  N Turjman; P P Nair
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

View more
  134 in total

1.  Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells.

Authors:  Xiaofang Huo; Stefanie Juergens; Xi Zhang; Davood Rezaei; Chunhua Yu; Eric D Strauch; Jian-Ying Wang; Edaire Cheng; Frank Meyer; David H Wang; Qiuyang Zhang; Stuart J Spechler; Rhonda F Souza
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-02       Impact factor: 4.052

Review 2.  Barrett's esophagus: environmental influences in the progression of dysplasia.

Authors:  Ralph A Boulton; Bernhard Usselmann; Imtiyaz Mohammed; Janusz Jankowski
Journal:  World J Surg       Date:  2003-07-28       Impact factor: 3.352

Review 3.  Risk factors for neoplastic progression in Barrett's esophagus.

Authors:  Elizabeth F Wiseman; Yeng S Ang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

4.  The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid.

Authors:  Heather B Roesly; Mohammad R Khan; Hwu Dau Rw Chen; Kimberly A Hill; Nirushan Narendran; George S Watts; Xiaoxin Chen; Katerina Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-02       Impact factor: 4.052

5.  Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study.

Authors:  Michael B Cook; Sanford M Dawsey; Lena Diaw; Martin J Blaser; Guillermo I Perez-Perez; Christian C Abnet; Philip R Taylor; Demetrius Albanes; Jarmo Virtamo; Farin Kamangar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

6.  Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Katerina Dvorak; George S Watts; Lois Ramsey; Hana Holubec; Claire M Payne; Carol Bernstein; Gareth J Jenkins; Richard E Sampliner; Anil Prasad; Harinder S Garewal; Harris Bernstein
Journal:  Am J Gastroenterol       Date:  2009-01-27       Impact factor: 10.864

7.  Oesophageal clearance of acid and bile: a combined radionuclide, pH, and Bilitec study.

Authors:  G H Koek; R Vos; P Flamen; D Sifrim; F Lammert; B Vanbilloen; J Janssens; J Tack
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

8.  [Antireflux therapy--more than acid reduction?].

Authors:  T Frieling
Journal:  Internist (Berl)       Date:  2004-12       Impact factor: 0.743

9.  Role of bile acids, prostaglandins and COX inhibitors in chronic esophagitis in a mouse model.

Authors:  C Poplawski; D Sosnowski; A Szaflarska-Popławska; J Sarosiek; R McCallum; Z Bartuzi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

10.  Hypoxia-inducible factor-2α plays a role in mediating oesophagitis in GORD.

Authors:  Xiaofang Huo; Agoston T Agoston; Kerry B Dunbar; Daisha J Cipher; Xi Zhang; Chunhua Yu; Edaire Cheng; Qiuyang Zhang; Thai H Pham; Uttam K Tambar; Richard K Bruick; David H Wang; Robert D Odze; Stuart J Spechler; Rhonda F Souza
Journal:  Gut       Date:  2016-09-30       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.